Skip to main content
Premium Trial:

Request an Annual Quote

Less Two Business Units, MWG Posts 43-Percent Decline in Q1 Revenue

NEW YORK, May 10 (GenomeWeb News) - MWG Biotech this week reported a 43-percent decline in total revenues for the first quarter of 2005, and reaffirmed its commitment to lay off nine staffers by the end of the year.


Total receipts for the three months ended March 31 fell to €5 million ($6.5 million) from €8.9 million in the prior-year period.


The company attributes the decline to the sale of its genomic diagnosis and genomic technologies units to Ocimum Biosolutions in March.


MWG also saw a slight decline in revenues for its remaining DNA/RNA synthesis and DNA sequencing units, which slid 16.6 percent to €5 million from €5.9 million in the same quarter of 2004.


Still, the company managed to cut its net losses to €30,000 from €2.43 million in the same quarter of 2004, although the DNA/RNA Synthesis and DNA Sequencing units only amounted to €35,000 of the 2004 net loss.


The company also noted that its overhead costs had declined by €4 million to €3 million over the past year, and reaffirmed its commitment to pare its 174 employees to 165 by the end of the year.


On the reporting date March 31, MWG Biotech had cash and cash equivalents worth €6.6 million.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.